97 related articles for article (PubMed ID: 27318685)
1. Human Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer Radiotherapy.
Eriksen JG; Lassen P
Recent Results Cancer Res; 2016; 198():143-61. PubMed ID: 27318685
[TBL] [Abstract][Full Text] [Related]
2. Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models.
Sørensen BS; Busk M; Horsman MR; Alsner J; Overgaard J; Kyle AH; Minchinton AI
Anticancer Res; 2014 Nov; 34(11):6297-304. PubMed ID: 25368228
[TBL] [Abstract][Full Text] [Related]
3. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
4. Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivity.
Vozenin MC; Lord HK; Hartl D; Deutsch E
Cancer Treat Rev; 2010 Dec; 36(8):629-36. PubMed ID: 20417037
[TBL] [Abstract][Full Text] [Related]
5. Longer survival in patients with human papillomavirus-related head and neck cancer after positive postradiation planned neck dissection.
Huang SH; Patel S; O'Sullivan B; Shen X; Xu W; Weinreb I; Perez-Ordonez B; Irish J; Waldron J; Gullane P; Gilbert R; Brown D; Kim J; Freeman J; de Almeida JR; Goldstein D
Head Neck; 2015 Jul; 37(7):946-52. PubMed ID: 24633991
[TBL] [Abstract][Full Text] [Related]
6. Experimental investigation of radiobiology in head and neck cancer cell lines as a function of HPV status, by MTT assay.
Reid P; Wilson P; Li Y; Marcu LG; Staudacher AH; Brown MP; Bezak E
Sci Rep; 2018 May; 8(1):7744. PubMed ID: 29773816
[TBL] [Abstract][Full Text] [Related]
7. The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.
Lassen P
Radiother Oncol; 2010 Jun; 95(3):371-80. PubMed ID: 20493569
[TBL] [Abstract][Full Text] [Related]
8. [Human papilloma virus in head and neck cancer].
Barry B; Ortholan C
Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.
Ringström E; Peters E; Hasegawa M; Posner M; Liu M; Kelsey KT
Clin Cancer Res; 2002 Oct; 8(10):3187-92. PubMed ID: 12374687
[TBL] [Abstract][Full Text] [Related]
11. Variation of HPV Subtypes with Focus on HPV-Infection and Cancer in the Head and Neck Region.
Wichmann G
Recent Results Cancer Res; 2017; 206():113-122. PubMed ID: 27699533
[TBL] [Abstract][Full Text] [Related]
12. HPV, hypoxia and radiation response in head and neck cancer.
Göttgens EL; Ostheimer C; Span PN; Bussink J; Hammond EM
Br J Radiol; 2019 Jan; 92(1093):20180047. PubMed ID: 29493265
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
14. Statistical analysis of human papillomavirus in a subset of upper aerodigestive tract tumors.
Liu H; Li J; Diao M; Cai Z; Yang J; Zeng Y
J Med Virol; 2013 Oct; 85(10):1775-85. PubMed ID: 23861229
[TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance.
Braakhuis BJ; Brakenhoff RH; Meijer CJ; Snijders PJ; Leemans CR
Eur J Cancer; 2009 Nov; 45(17):2935-9. PubMed ID: 19766476
[TBL] [Abstract][Full Text] [Related]
16. Future treatment directions for HPV-associated head and neck cancer based on radiobiological rationale and current clinical evidence.
Marcu LG
Crit Rev Oncol Hematol; 2016 Jul; 103():27-36. PubMed ID: 27221393
[TBL] [Abstract][Full Text] [Related]
17. Modulation of therapeutic sensitivity by human papillomavirus.
Swick AD; Chatterjee A; De Costa AM; Kimple RJ
Radiother Oncol; 2015 Sep; 116(3):342-5. PubMed ID: 26364887
[TBL] [Abstract][Full Text] [Related]
18. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J;
Radiother Oncol; 2010 Jan; 94(1):30-5. PubMed ID: 19910068
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.
Gooi Z; Chan JY; Fakhry C
Laryngoscope; 2016 Apr; 126(4):894-900. PubMed ID: 26845348
[TBL] [Abstract][Full Text] [Related]
20. The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.
Zhu X; Wang Y; Zhu H; Lou W
Acta Otolaryngol; 2016 Dec; 136(12):1291-1298. PubMed ID: 27472193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
